Webinar: Accelerate late-phase drug development with continuous manufacturing

The process development of oral solid dosage forms occurs across multiple phases. The final scaled up process is not typically finalized until shortly before filing for commercial approval. Continuous manufacturing is well suited for phase III development and clinical manufacturing and enables late-phase development by ensuring a greater quality assurance and reducing API usage. Additionally, continuous manufacturing doesn’t require scale up and expedites readiness from phase III to commercial.

Attend this webinar to learn more about

  • Building and executing a late-phase strategy that reduces total cost of ownership
  • Shortening scale-up activities to get to market quicker
  • Evaluating a build vs outsourcing continuous manufacturing model
  • Case studies

Featured Speakers

Doug Hausner

Senior Manager for Continuous Manufacturing Business Development

Thermo Fisher Scientific

Doug is the Senior Manager for Continuous Manufacturing Business Development at Thermo Fisher Scientific. He is a subject matter expert in continuous manufacturing. Prior to joining Thermo Fisher Scientific, Doug spent 9 years leading the development of continuous manufacturing technology at Rutgers University and the NSF Engineering Research Center, C-SOPS.


© 2021 Questex LLC, All right reserved.

685 Third Avenue, 21st Floor New York, NY 10017

Reproduction in whole or part is prohibited.